deferiprone has been researched along with Nephrogenic Fibrosing Dermopathy in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Nephrogenic Fibrosing Dermopathy: A chronic, acquired, idiopathic, progressive eruption of the skin that occurs in the context of RENAL FAILURE. It is sometimes accompanied by systemic fibrosis. The pathogenesis seems to be multifactorial, with postulated involvement of circulating fibrocytes. There is a strong association between this disorder and the use of gadolinium-based contrast agents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nephrogenic systemic fibrosis is associated with gadolinium contrast exposure in patients with reduced kidney function and carries high morbidity and mortality." | 3.81 | Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis. ( Bose, C; Hall, KA; Hiatt, KM; Karaduta, O; Megyesi, JK; Shah, SV; Swaminathan, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, C | 1 |
| Megyesi, JK | 1 |
| Shah, SV | 1 |
| Hiatt, KM | 1 |
| Hall, KA | 1 |
| Karaduta, O | 1 |
| Swaminathan, S | 1 |
1 other study available for deferiprone and Nephrogenic Fibrosing Dermopathy
| Article | Year |
|---|---|
Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis.
Topics: Animals; Contrast Media; Deferiprone; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Humans; I | 2015 |